Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Plasma levels of mitochondrial and nuclear DNA in patients with massive pulmonary embolism in the emergency department: a prospective cohort study.

Arnalich F, Maldifassi MC, Ciria E, Codoceo R, Renart J, Fernández-Capitán C, Herruzo R, Garcia-Rio F, López-Collazo E, Montiel C.

Crit Care. 2013 May 24;17(3):R90. doi: 10.1186/cc12735.

2.

Predictive value of the heart-type fatty acid-binding protein and the Pulmonary Embolism Severity Index in patients with acute pulmonary embolism in the emergency department.

Lauque D, Maupas-Schwalm F, Bounes V, Juchet H, Bongard V, Roshdy A, Botella JM, Charpentier S.

Acad Emerg Med. 2014 Oct;21(10):1143-50. doi: 10.1111/acem.12484.

3.

Prognostic value of cell-free plasma DNA in patients with cardiac arrest outside the hospital: an observational cohort study.

Arnalich F, Menéndez M, Lagos V, Ciria E, Quesada A, Codoceo R, Vazquez JJ, López-Collazo E, Montiel C.

Crit Care. 2010;14(2):R47. doi: 10.1186/cc8934. Epub 2010 Mar 29.

4.

The predictive value of heart-type fatty acid-binding protein is independent from symptom duration in normotensive patients with pulmonary embolism.

Lankeit M, Dellas C, Benz V, Hasenfuß G, Konstantinides S.

Thromb Res. 2013 Nov;132(5):543-7. doi: 10.1016/j.thromres.2013.09.022. Epub 2013 Sep 24.

PMID:
24094603
5.

Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism.

Dellas C, Puls M, Lankeit M, Schäfer K, Cuny M, Berner M, Hasenfuss G, Konstantinides S.

J Am Coll Cardiol. 2010 May 11;55(19):2150-7. doi: 10.1016/j.jacc.2009.10.078.

6.

Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study.

Vuilleumier N, Le Gal G, Verschuren F, Perrier A, Bounameaux H, Turck N, Sanchez JC, Mensi N, Perneger T, Hochstrasser D, Righini M.

J Thromb Haemost. 2009 Mar;7(3):391-8. doi: 10.1111/j.1538-7836.2008.03260.x.

7.

Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolism.

Langer M, Forkmann M, Richter U, Tausche AK, Sveric K, Christoph M, Ibrahim K, Günther M, Kolschmann S, Boscheri A, Barthel P, Strasser RH, Wunderlich C.

J Crit Care. 2016 Oct;35:174-9. doi: 10.1016/j.jcrc.2016.05.014. Epub 2016 May 26.

PMID:
27481755
8.

The prognostic and risk-stratified value of heart-type fatty acid-binding protein in septic patients in the emergency department.

Chen YX, Li CS.

J Crit Care. 2014 Aug;29(4):512-6. doi: 10.1016/j.jcrc.2014.03.026. Epub 2014 Apr 2.

PMID:
24768564
9.

Thrombolysis in patients with pulmonary embolism and elevated heart-type fatty acid-binding protein levels.

Gul EE, Can I, Kayrak M, Abdulhalikov T, Erdogan HI, Altunbas G, Ozdemir K, Gok H.

J Thromb Thrombolysis. 2014 May;37(4):483-9. doi: 10.1007/s11239-013-1008-7.

PMID:
24264959
10.

Heart-type fatty acid-binding protein as a prognostic factor in patients with severe sepsis and septic shock.

Jo YH, Kim K, Lee JH, Rhee JE, Lee JH, Kang KW, Rim KP, Hwang SS, Park HM.

Am J Emerg Med. 2012 Nov;30(9):1749-55. doi: 10.1016/j.ajem.2012.02.005. Epub 2012 Mar 29.

PMID:
22463971
11.

Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis.

Bajaj A, Rathor P, Sehgal V, Kabak B, Shetty A, Al Masalmeh O, Hosur S.

Lung. 2015 Oct;193(5):639-51. doi: 10.1007/s00408-015-9752-4. Epub 2015 Jul 2. Review.

PMID:
26134045
12.

Acute pulmonary embolism: analysis of consecutive 353 patients hospitalised in a single centre. A 3-year experience.

Labyk A, Ciurzyński M, Jankowski K, Kostrubiec M, Lichodziejewska B, Bienias P, Pedowska-Włoszek J, Pacho S, Palczewski P, Pruszczyk P.

Kardiol Pol. 2012;70(1):15-22.

13.
14.

The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism.

Douketis JD, Leeuwenkamp O, Grobara P, Johnston M, Söhne M, Ten Wolde M, Büller H.

J Thromb Haemost. 2005 Mar;3(3):508-13.

15.

A simple score for rapid risk assessment of non-high-risk pulmonary embolism.

Lankeit M, Friesen D, Schäfer K, Hasenfuß G, Konstantinides S, Dellas C.

Clin Res Cardiol. 2013 Jan;102(1):73-80. doi: 10.1007/s00392-012-0498-1. Epub 2012 Aug 9.

16.

Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension.

Lankeit M, Dellas C, Panzenböck A, Skoro-Sajer N, Bonderman D, Olschewski M, Schäfer K, Puls M, Konstantinides S, Lang IM.

Eur Respir J. 2008 May;31(5):1024-9. doi: 10.1183/09031936.00100407. Epub 2008 Feb 6.

17.

Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism.

Ozsu S, Karaman K, Mentese A, Ozsu A, Karahan SC, Durmus I, Oztuna F, Kosucu P, Bulbul Y, Ozlu T.

Thromb Res. 2010 Dec;126(6):486-92. doi: 10.1016/j.thromres.2010.08.021.

PMID:
20920821
18.

Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism.

Moores L, Aujesky D, Jiménez D, Díaz G, Gómez V, Martí D, Briongos S, Yusen R.

J Thromb Haemost. 2010 Mar;8(3):517-22. doi: 10.1111/j.1538-7836.2009.03725.x. Epub 2009 Dec 15.

19.

Prognostic significance of cardiac troponin I on admission for surgical treatment of acute pulmonary embolism: a single-centre experience over more than 10 years.

Thielmann M, Pasa S, Wendt D, Price V, Marggraf G, Neuhäuser M, Piotrowski A, Jakob H.

Eur J Cardiothorac Surg. 2012 Dec;42(6):951-7. doi: 10.1093/ejcts/ezs122. Epub 2012 Apr 4.

PMID:
22491666
20.

Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk.

Boscheri A, Wunderlich C, Langer M, Schoen S, Wiedemann B, Stolte D, Elmer G, Barthel P, Strasser RH.

Am Heart J. 2010 Aug;160(2):294-300. doi: 10.1016/j.ahj.2010.05.010.

PMID:
20691835

Supplemental Content

Support Center